Resources

This public summary document outlines Stoma Product Assessment Panel recommendations, after assessing products for the Stoma Appliance Scheme Schedule in October 2023.

This public summary document outlines Stoma Product Assessment Panel recommendations, after assessing products for the Stoma Appliance Scheme Schedule in October 2023.

This publication provides principles and recommendations for the implementation and management of universal aftercare. We engaged the Sax Institute to review the evidence on effective universal aftercare services for the years 2019 to 2022.

These infographics highlight the key facts of the 2022–23 report on the operation of the Aged Care Act 1997 (ROACA). They include statistics on aged care providers, expenditure and types of aged care services.

Health Technology Assessment Policy and Methods Review Reference Committee agenda for the 32nd meeting on 18 December 2023.

Health Technology Assessment Policy and Methods Review Reference Committee agenda for the 31st meeting on 15 December 2023.

Health Technology Assessment Policy and Methods Review Reference Committee agenda for the 30th meeting on 14 December 2023.

In this webinar we looked at our November 2023 releases, highlighted our achievements for the year and our plans for 2024.

This communique provides a summary of the advisory committee's meeting on 8 December 2023.

A report on the review of the Australian Brain Cancer Mission.

This document is about sharing information in the allied health sector. It looks at allied health information sharing from the view point of healthcare providers and healthcare recipients.

This report looks at issues with digital readiness in the allied health sector.

This document sets out points to consider for doctors providing clinical opinion in support of COVID-19 vaccine injury claims following vaccination with a TGA approved vaccine.

This document sets out points to consider for doctors providing clinical opinion in support of COVID-19 vaccine injury claims following vaccination with a TGA approved vaccine.

This document outlines the details of COVID-19 vaccines claims scheme to reimburse people who suffer a moderate to significant impact following an adverse reaction to an approved COVID-19 vaccine.

This document outlines the frequently asked questions of COVID-19 vaccines claims scheme to reimburse people who suffer a moderate to significant impact following an adverse reaction to an approved COVID-19 vaccine.

This document provides answers to the questions raised during the Publishing provider reporting for stakeholders and the community webinar on 28 November 2023.

This A3 poster was developed to help promote the Medical Costs Finder Website.

This report summarises the feedback received from the new Aged Care Act foundations consultation held in August and September 2023.

This quick reference guide is designed to support Organisation Administrators to add new Financial Reporting users to the GPMS provider portal so they can access the QFR application.

Trachoma is the world’s leading infectious cause of preventable blindness. In Australia, it occurs primarily in remote and very remote Aboriginal communities in the Northern Territory, South Australia, and Western Australia. This document reports on the prevalence of trachoma in Australia in 2022.